Skip to main content
. Author manuscript; available in PMC: 2016 May 23.
Published in final edited form as: Am J Gastroenterol. 2015 Jul 21;110(8):1233–1239. doi: 10.1038/ajg.2015.217

Figure 2.

Figure 2

(a) Survival by prior statin use, log-rank P=0.0035. Median survival (95% confidence limits) in months: simvastatin, 28.5 (20.8, 38.4); lovastatin, 12.9 (9.6, 15.5); no statin, 16.5 (14.1, 18.9). (b) Survival stratified by statin status at baseline, log-rank P=0.013. Median survival (95% confidence limits) in months: no prior statin, 16.7 (14.4, 19.6); active simvastatin, 31.6 (20.9, 43.8); active lovastatin, 10.7 (7.67,26.7); former simvastatin, 19.4 (6.5, 28.5); former lovastatin, 14.1 (8.1, 15.5).